Contribution
My Lords, before I start, I must ask myself why I volunteer to come in on Fridays. The last time I was in on a Friday, it was the assisted dying Bill, and now we have an abortion Bill. I should be more careful before volunteering to do Front-Bench duty.
I thank my noble friend Lord Moylan for setting out the case for the Bill and all noble Lords, whatever their views, who spoke in this debate. As someone who studied engineering and maths and later worked with econometricians, noble Lords may realise that I am slightly geeky about the need for reliable data and statistics; in fact, the noble Baroness, Lady Freeman, has often pointed that out to me.
Noble Lords will be aware that I often question the Minister on what data is collected in order to make better decisions and improve the standard of health and social care. The Bill itself calls for the publication of an annual report on complications from abortions. We have heard it said that, where possible, hospital episode statistics and abortion notification system complication rates should be collected, alongside those for incomplete abortions, in order to improve patient safety.
As my noble friend Lord Moylan said, Parliament expressed its will that such data be reported confidentially and securely to the Chief Medical Officer, under Section 2 of the Abortion Act 1967, which gives effect to the Abortion Regulations 1991 that require doctors carrying out abortions to notify the relevant person of any complications that occurred during the course of an abortion. The law is therefore already clear that data relating to complications as a result of abortions should be collected and reported to the Minister for Health or the Chief Medical Officer.
However, as many noble Lords have pointed out, since 1967, due to medical advances, the method of abortion has changed, with medical abortions typically using mifepristone or misoprostol accounting for 87% of abortions. In fact, 72% of all abortions now occur at home. The statistics have not necessarily kept up with these medical advances. That is a pity because, as in other parts of healthcare, it is important—I think all noble Lords agree—to collect accurate data to understand the reasons for complications from abortions in order to make them safer for women who have medical abortions.
The safety rate may well be very high but, where there are complications, we should be trying to make those figures even higher. If some of the complications are, for example, due to medication being taken at the wrong time, we would hope that such data would put pressure on the big pharma companies that produce these pills to improve patient awareness in order to increase their safety. Where there are complications, we should not allow the big pharma companies to hide behind the larger debate on abortion.
I have also heard concerns that this Bill would somehow exceptionalise abortion. I understand the concern, but patient safety should be our primary concern. In this House, we regularly debate particular problems that require attention, quite often on a Friday in relation to Private Members’ Bills. When we debate Private Members’ Bills, we are inevitably focused on narrow areas of policy, since we have only limited time to debate them. Let us take the Corporate Waste Responsibility Bill, which was debated earlier: it focused on fly-tipping, but I do not think anyone would criticise the noble Baroness, Lady Sheehan, for exceptionalising that issue. I really see the question as whether the Minister’s department collects and publishes information on which clinicians, patients and the public can properly rely. It would be a pity if data collection is characterised as exceptionalising abortion rather than seeking to improve patient safety.
Having said all that, like other noble Lords, I have to ask whether primary legislation is the most appropriate means of achieving better statistics. Indeed, my noble friend Lord Moylan told your Lordships in 2024, and again today, that the Government could deliver improved reporting on this topic without legislation. Noble Lords have also referred to the fact that the DHSC has explained the reasons for the delay in the statistics. Can the Minister explain what practical steps the Government are taking to collect accurate data on complications from abortions, as my noble friend Lady Sugg asked, and whether that is through the proposed single patient record? It if is, how will that respect patient privacy and confidentiality?
These are issues that I know we will discuss next week when debating the single patient record under the Health Bill. There is a concern within that Bill about the duty of confidentiality in new Section 250E(3), inserted by Clause 52, which in effect proposes the removal of the common-law duty of confidentiality. We will have to come back to this in the Health Bill debate.
What conversations are the department having with big pharma companies producing medical abortion pills to improve patient safety overall, so that feedback gets back to them and they can understand where there are complications, however small they might be, so that we can get even higher safety statistics than we already have and many noble Lords are proud of?
I look forward to the Minister’s response. I also hope that it is enough to persuade my noble friend Lord Moylan that perhaps the primary legislation is not needed and that the Government are working towards the goal that he seeks.